Fig. 2From: Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCTSchematic plots of survival and GVHD events of each CAEBV patient after haplo-HSCT. No relapse was observed. Triangle: death; circle: acute GVHD; square: chronic GVHD; arrow: aliveBack to article page